HEART DISEASES AND CHRONIC HEART FAILURE: COMPARATIVE CHARACTERISTICS OF DEGENERATIVE VALVE MEDICAL TREATMENT
With an increase in life expectancy, the proportion of heart defects increases as a result of the progression of atherosclerosis and sclero - degenerative changes in the connective tissue of the heart in elderly and old people. According to literature data, in recent years, the number of patients with acquired aortic and mitral valve defects has increased by 15-20%. Heart defects are often complicated by chronic heart failure, which leads to a more severe course of the disease and worsens the prognosis. Based on the above, the question of the selection of the most rational and effective drug therapy for the treatment of patients with degenerative valvular heart disease remains highly relevant.